ArticleFrontiers in immunology2023

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer.

Chengpei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.